A citation-based method for searching scientific literature

Rodolphe Jantzen, Yves Payette, Thibault de Malliard, Catherine Labbé, Nolwenn Noisel, Philippe Broët. BMJ Open 2021
Times Cited: 1

List of co-cited articles
articles co-cited >1

Times Cited
  Times     Co-cited

Validation of the breast cancer surveillance consortium model of breast cancer risk.
Jeffrey A Tice, Michael C S Bissell, Diana L Miglioretti, Charlotte C Gard, Garth H Rauscher, Firas M Dabbous, Karla Kerlikowske. Breast Cancer Res Treat 2019

Development of a personalized decision aid for breast cancer risk reduction and management.
Elissa M Ozanne, Rebecca Howe, Zehra Omer, Laura J Esserman. BMC Med Inform Decis Mak 2014

Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.
Jack Cuzick, Ivana Sestak, Simon Cawthorn, Hisham Hamed, Kaija Holli, Anthony Howell, John F Forbes. Lancet Oncol 2015

Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials.
Jack Cuzick, Adam R Brentnall, Corrinne Segal, Helen Byers, Caroline Reuter, Simone Detre, Elena Lopez-Knowles, Ivana Sestak, Anthony Howell, Trevor J Powles,[...]. J Clin Oncol 2017

Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis.
S G Smith, I Sestak, A Forster, A Partridge, L Side, M S Wolf, R Horne, J Wardle, J Cuzick. Ann Oncol 2016

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.
Kyriaki Michailidou, Jonathan Beesley, Sara Lindstrom, Sander Canisius, Joe Dennis, Michael J Lush, Mel J Maranian, Manjeet K Bolla, Qin Wang, Mitul Shah,[...]. Nat Genet 2015

Breast cancer risk prediction using a clinical risk model and polygenic risk score.
Yiwey Shieh, Donglei Hu, Lin Ma, Scott Huntsman, Charlotte C Gard, Jessica W T Leung, Jeffrey A Tice, Celine M Vachon, Steven R Cummings, Karla Kerlikowske,[...]. Breast Cancer Res Treat 2016

The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care.
Sarah L Elson, Robert A Hiatt, Hoda Anton-Culver, Lydia P Howell, Arash Naeim, Barbara A Parker, Laura J Van't Veer, Michael Hogarth, John P Pierce, Robert J Duwors,[...]. Breast Cancer Res Treat 2013

Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic.
L S Donnelly, D G Evans, J Wiseman, J Fox, R Greenhalgh, J Affen, I Juraskova, P Stavrinos, S Dawe, J Cuzick,[...]. Br J Cancer 2014

Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups.
Celia Patricia Kaplan, Jennifer S Haas, Eliseo J Pérez-Stable, Steven E Gregorich, Carol Somkin, Genevieve Des Jarlais, Karla Kerlikowske. Cancer Epidemiol Biomarkers Prev 2006

Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial.
Holly Keane, Yash S Huilgol, Yiwey Shieh, Jeffrey A Tice, Jeff Belkora, Karen Sepucha, W Patrick Shibley, Tianyi Wang, Mandy Che, Deborah Goodman,[...]. NPJ Breast Cancer 2021

How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
Katherine D Crew, Kathy S Albain, Dawn L Hershman, Joseph M Unger, Shelly S Lo. NPJ Breast Cancer 2017

A new selection method to increase the health benefits of CVD prevention strategies.
Ghizelda R Lagerweij, G Ardine de Wit, Karel Gm Moons, Yvonne T van der Schouw, Wm Monique Verschuren, Jannick An Dorresteijn, Hendrik Koffijberg. Eur J Prev Cardiol 2018

Perceived risk of breast cancer among women at average and increased risk.
Jennifer S Haas, Celia P Kaplan, Genevieve Des Jarlais, Virginia Gildengoin, Eliseo J Pérez-Stable, Karla Kerlikowske. J Womens Health (Larchmt) 2005

Risk estimates from an online risk calculator are more believable and recalled better when expressed as integers.
Holly O Witteman, Brian J Zikmund-Fisher, Erika A Waters, Teresa Gavaruzzi, Angela Fagerlin. J Med Internet Res 2011

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.
B Rockhill, D Spiegelman, C Byrne, D J Hunter, G A Colditz. J Natl Cancer Inst 2001

Statistics review 14: Logistic regression.
Viv Bewick, Liz Cheek, Jonathan Ball. Crit Care 2005

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019

Breast cancer risk assessment and prevention: a framework for shared decision-making consultations.
Elissa M Ozanne, Jennifer R Klemp, Laura J Esserman. Breast J 2006

Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Stephanie R Land, D Lawrence Wickerham, Joseph P Costantino, Marcie W Ritter, Victor G Vogel, Myoungkeun Lee, Eduardo R Pajon, James L Wade, Shaker Dakhil, James B Lockhart,[...]. JAMA 2006

Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.
Trevor J Powles, Sue Ashley, Alwynne Tidy, Ian E Smith, Mitch Dowsett. J Natl Cancer Inst 2007

Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
Xuehong Zhang, Megan Rice, Shelley S Tworoger, Bernard A Rosner, A Heather Eliassen, Rulla M Tamimi, Amit D Joshi, Sara Lindstrom, Jing Qian, Graham A Colditz,[...]. PLoS Med 2018

Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010.
Erika A Waters, Timothy S McNeel, Worta McCaskill Stevens, Andrew N Freedman. Breast Cancer Res Treat 2012

Risky feelings: why a 6% risk of cancer does not always feel like 6%.
Brian J Zikmund-Fisher, Angela Fagerlin, Peter A Ubel. Patient Educ Couns 2010

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Bernard Fisher, Joseph P Costantino, D Lawrence Wickerham, Reena S Cecchini, Walter M Cronin, Andre Robidoux, Therese B Bevers, Maureen T Kavanah, James N Atkins, Richard G Margolese,[...]. J Natl Cancer Inst 2005

Validation studies for models projecting the risk of invasive and total breast cancer incidence.
J P Costantino, M H Gail, D Pee, S Anderson, C K Redmond, J Benichou, H S Wieand. J Natl Cancer Inst 1999

Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.
M H Gail, J P Costantino, J Bryant, R Croyle, L Freedman, K Helzlsouer, V Vogel. J Natl Cancer Inst 1999

Understanding Decision Making about Breast Cancer Prevention in Action: The Intersection of Perceived Risk, Perceived Control, and Social Context: NRG Oncology/NSABP DMP-1.
Christine M Gunn, Barbara G Bokhour, Victoria A Parker, Tracy A Battaglia, Patricia A Parker, Angela Fagerlin, Worta McCaskill-Stevens, Hanna Bandos, Sarah B Blakeslee, Christine Holmberg. Med Decis Making 2019

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.
Kala Visvanathan, Patricia Hurley, Elissa Bantug, Powel Brown, Nananda F Col, Jack Cuzick, Nancy E Davidson, Andrea Decensi, Carol Fabian, Leslie Ford,[...]. J Clin Oncol 2013

Uptake of breast cancer prevention and screening trials.
D Gareth Evans, Michelle Harvie, Nigel Bundred, Anthony Howell. J Med Genet 2010

Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
Adam R Brentnall, Jack Cuzick, Diana S M Buist, Erin J Aiello Bowles. JAMA Oncol 2018

A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.
Adam R Brentnall, Elke M van Veen, Elaine F Harkness, Sajjad Rafiq, Helen Byers, Susan M Astley, Sarah Sampson, Anthony Howell, William G Newman, Jack Cuzick,[...]. Int J Cancer 2020

NRG Oncology/National Surgical Adjuvant Breast and Bowel Project Decision-Making Project-1 Results: Decision Making in Breast Cancer Risk Reduction.
Christine Holmberg, Hanna Bandos, Angela Fagerlin, Therese B Bevers, Tracy A Battaglia, D Lawrence Wickerham, Worta J McCaskill-Stevens. Cancer Prev Res (Phila) 2017

Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor.
Meghan R Flanagan, Emily C Zabor, Michelle Stempel, Debra A Mangino, Monica Morrow, Melissa L Pilewskie. Ann Surg Oncol 2019

Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
Kyriaki Michailidou, Per Hall, Anna Gonzalez-Neira, Maya Ghoussaini, Joe Dennis, Roger L Milne, Marjanka K Schmidt, Jenny Chang-Claude, Stig E Bojesen, Manjeet K Bolla,[...]. Nat Genet 2013

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
Yiwey Shieh, Martin Eklund, Lisa Madlensky, Sarah D Sawyer, Carlie K Thompson, Allison Stover Fiscalini, Elad Ziv, Laura J Van't Veer, Laura J Esserman, Jeffrey A Tice. J Natl Cancer Inst 2017

Physician and Patient Barriers to Breast Cancer Preventive Therapy.
Susan Hum, Melinda Wu, Sandhya Pruthi, Ruth Heisey. Curr Breast Cancer Rep 2016

Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.
Andrew N Freedman, Binbing Yu, Mitchell H Gail, Joseph P Costantino, Barry I Graubard, Victor G Vogel, Garnet L Anderson, Worta McCaskill-Stevens. J Clin Oncol 2011

Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial.
Jack Cuzick, Ivana Sestak, John F Forbes, Mitch Dowsett, Simon Cawthorn, Robert E Mansel, Sibylle Loibl, Bernardo Bonanni, D Gareth Evans, Anthony Howell. Lancet 2020

Exemestane for breast-cancer prevention in postmenopausal women.
Paul E Goss, James N Ingle, José E Alés-Martínez, Angela M Cheung, Rowan T Chlebowski, Jean Wactawski-Wende, Anne McTiernan, John Robbins, Karen C Johnson, Lisa W Martin,[...]. N Engl J Med 2011

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.